{"ticker": "BIXT", "overview": {"cik": "1445815", "ticker": "BIXT", "name": "BIOXYTRAN, INC", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023538", "price_sensitive": true}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016798", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-04-01", "title": "Form NT 10-K", "accession": "0001493152-26-014474", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-20", "title": "Material event", "accession": "0001493152-26-011755", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010045", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-02", "title": "Material event", "accession": "0001493152-26-008475", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-17", "title": "Material event", "accession": "0001493152-26-006891", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-11", "title": "Material event", "accession": "0001493152-26-006081", "price_sensitive": true}, {"form": "8-K", "date": "2026-01-05", "title": "Material event", "accession": "0001493152-26-000418", "price_sensitive": true}, {"form": "8-K", "date": "2025-12-15", "title": "Material event", "accession": "0001493152-25-027639", "price_sensitive": true}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000011", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000010", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000009", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000008", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000007", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000006", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001754429-25-000012", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-14", "title": "Quarterly report", "accession": "0001493152-25-023399", "price_sensitive": true}, {"form": "10-Q", "date": "2025-08-11", "title": "Quarterly report", "accession": "0001493152-25-011797", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-15", "title": "Quarterly report", "accession": "0001641172-25-010822", "price_sensitive": true}, {"form": "10-K", "date": "2025-04-03", "title": "Annual report", "accession": "0001641172-25-002614", "price_sensitive": true}, {"form": "8-K/A", "date": "2025-04-03", "title": "Form 8-K/A", "accession": "0001641172-25-002602", "price_sensitive": false}, {"form": "NT 10-K", "date": "2025-03-31", "title": "Form NT 10-K", "accession": "0001641172-25-001878", "price_sensitive": false}, {"form": "424B4", "date": "2025-02-18", "title": "Form 424B4", "accession": "0001493152-25-007059", "price_sensitive": false}, {"form": "EFFECT", "date": "2025-02-14", "title": "Form EFFECT", "accession": "9999999995-25-000468", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 2, "buy_sum": 323522.204, "sell_n": 0, "sell_sum": 0, "net": 323522.204, "insiders": 2, "first_date": "2024-08-15", "last_date": "2025-11-18"}, "metrics": {"ticker": "BIXT", "has_prices": false}, "trades": [{"id": "0001445815-25-000011", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 126000.0, "score": 40.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board member picks up $126K of BIXT", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000011/0001445815-25-000011-index.htm", "trade_date": "2025-11-18", "timestamp": "2025-11-18", "mins": 503509}, {"id": "0001445815-25-000008", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Anders Utter", "who_key": "Utter Anders", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 13505.8, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000008/0001445815-25-000008-index.htm", "trade_date": "2025-11-14", "timestamp": "2025-11-14", "mins": 509269}, {"id": "0001445815-25-000009", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Dale H. Conaway", "who_key": "CONAWAY DALE H", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 18558.045, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000009/0001445815-25-000009-index.htm", "trade_date": "2025-11-14", "timestamp": "2025-11-14", "mins": 509269}, {"id": "0001445815-25-000010", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Radka Milanova", "who_key": "MILANOVA RADKA", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 18558.045, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000010/0001445815-25-000010-index.htm", "trade_date": "2025-11-14", "timestamp": "2025-11-14", "mins": 509269}, {"id": "0001754429-25-000001", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Anders Utter", "who_key": "Utter Anders", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 30723.525, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442925000001/0001754429-25-000001-index.htm", "trade_date": "2025-01-06", "timestamp": "2025-01-06", "mins": 958549}, {"id": "0001754429-25-000002", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 30723.525, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442925000002/0001754429-25-000002-index.htm", "trade_date": "2025-01-06", "timestamp": "2025-01-06", "mins": 958549}, {"id": "0001754429-25-000003", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Dale H. Conaway", "who_key": "CONAWAY DALE H", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 30723.525, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442925000003/0001754429-25-000003-index.htm", "trade_date": "2025-01-06", "timestamp": "2025-01-06", "mins": 958549}, {"id": "0001754429-25-000004", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Radka Milanova", "who_key": "MILANOVA RADKA", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 30723.525, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442925000004/0001754429-25-000004-index.htm", "trade_date": "2025-01-06", "timestamp": "2025-01-06", "mins": 958549}, {"id": "0001754429-24-000008", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 9484.74, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000008/0001754429-24-000008-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000009", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Ola Soderquist", "who_key": "Soderquist Ola", "role": "CFO, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 5558697.995, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000009/0001754429-24-000009-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000010", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Dale H. Conaway", "who_key": "CONAWAY DALE H", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 9484.74, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000010/0001754429-24-000010-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000012", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Anders Utter", "who_key": "Utter Anders", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 9484.74, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000012/0001754429-24-000012-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000013", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 10112933.815000001, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000013/0001754429-24-000013-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000014", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Radka Milanova", "who_key": "MILANOVA RADKA", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 9484.74, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000014/0001754429-24-000014-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-25-000012", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Ola Soderquist", "who_key": "Soderquist Ola", "role": "CFO, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 5488820.82, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442925000012/0001754429-25-000012-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001445815-25-000006", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Michael Sheikh", "who_key": "Sheikh Michael", "role": "CCO, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 3605022.4000000004, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000006/0001445815-25-000006-index.htm", "trade_date": "2024-10-25", "timestamp": "2024-10-25", "mins": 1063669}, {"id": "0001754429-24-000011", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Michael Sheikh", "who_key": "Sheikh Michael", "role": "Chief Communications Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 3528286.9450000003, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000011/0001754429-24-000011-index.htm", "trade_date": "2024-10-24", "timestamp": "2024-10-24", "mins": 1065109}, {"id": "0001445815-25-000007", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 10245571.01, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000007/0001445815-25-000007-index.htm", "trade_date": "2024-10-24", "timestamp": "2024-10-24", "mins": 1065109}, {"id": "0001754429-24-000001", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 375417.868, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000001/0001754429-24-000001-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000002", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Dale H. Conaway", "who_key": "CONAWAY DALE H", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 369069.9, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000002/0001754429-24-000002-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000003", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Anders Utter", "who_key": "Utter Anders", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 371132.542, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000003/0001754429-24-000003-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000005", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Radka Milanova", "who_key": "MILANOVA RADKA", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 57853.035, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000005/0001754429-24-000005-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000006", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Michael Sheikh", "who_key": "Sheikh Michael", "role": "Chief Communications Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 48000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000006/0001754429-24-000006-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000007", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Ola Soderquist", "who_key": "Soderquist Ola", "role": "CFO, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 214888.3, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000007/0001754429-24-000007-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160149}, {"id": "0001754429-24-000004", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 197522.204, "score": 53.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO buys $198K of BIXT", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000004/0001754429-24-000004-index.htm", "trade_date": "2024-08-15", "timestamp": "2024-08-15", "mins": 1165909}, {"id": "0001445815-24-000011", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 10000.065999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581524000011/0001445815-24-000011-index.htm", "trade_date": "2024-04-19", "timestamp": "2024-04-19", "mins": 1335829}, {"id": "0001445815-24-000012", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Dale H. Conaway", "who_key": "CONAWAY DALE H", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 10000.065999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581524000012/0001445815-24-000012-index.htm", "trade_date": "2024-04-19", "timestamp": "2024-04-19", "mins": 1335829}, {"id": "0001445815-24-000013", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Radka Milanova", "who_key": "MILANOVA RADKA", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 10000.065999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581524000013/0001445815-24-000013-index.htm", "trade_date": "2024-04-19", "timestamp": "2024-04-19", "mins": 1335829}, {"id": "0001445815-24-000006", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 30432.870000000003, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581524000006/0001445815-24-000006-index.htm", "trade_date": "2024-03-27", "timestamp": "2024-03-27", "mins": 1368949}, {"id": "0001445815-24-000007", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 45717.88, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on BIXT \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581524000007/0001445815-24-000007-index.htm", "trade_date": "2024-03-27", "timestamp": "2024-03-27", "mins": 1368949}], "recent_buys": [{"id": "0001445815-25-000011", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 126000.0, "score": 40.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board member picks up $126K of BIXT", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000011/0001445815-25-000011-index.htm", "trade_date": "2025-11-18", "timestamp": "2025-11-18", "mins": 503509}, {"id": "0001754429-24-000004", "src": "INSIDERS", "ticker": "BIXT", "cik": "1445815", "company": "BIOXYTRAN, INC", "company_raw": "BIOXYTRAN, INC", "who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 197522.204, "score": 53.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO buys $198K of BIXT", "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000004/0001754429-24-000004-index.htm", "trade_date": "2024-08-15", "timestamp": "2024-08-15", "mins": 1165909}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "No longer listed", "items": [{"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "BIXT", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.853191"}]}, "key_people": [{"who": "David Platt", "who_key": "PLATT DAVID", "role": "CEO, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "bought": 197522.204, "sold": 0, "net": 197522.204, "trades": 1, "top_score": 53.8, "lean": "buying", "history": [{"action": "BUY", "amount": 197522.204, "date": "2024-08-15", "score": 53.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000004/0001754429-24-000004-index.htm"}], "latest": {"action": "BUY", "amount": 197522.204, "date": "2024-08-15", "score": 53.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000175442924000004/0001754429-24-000004-index.htm"}}, {"who": "Alan M. Hoberman", "who_key": "Hoberman Alan M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 126000.0, "sold": 0, "net": 126000.0, "trades": 1, "top_score": 40.2, "lean": "buying", "history": [{"action": "BUY", "amount": 126000.0, "date": "2025-11-18", "score": 40.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000011/0001445815-25-000011-index.htm"}], "latest": {"action": "BUY", "amount": 126000.0, "date": "2025-11-18", "score": 40.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1445815/000144581525000011/0001445815-25-000011-index.htm"}}], "activity": [], "announcements": [{"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023538", "price_sensitive": true}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016798", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-04-01", "title": "Form NT 10-K", "accession": "0001493152-26-014474", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-20", "title": "Material event", "accession": "0001493152-26-011755", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010045", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-02", "title": "Material event", "accession": "0001493152-26-008475", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-17", "title": "Material event", "accession": "0001493152-26-006891", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-11", "title": "Material event", "accession": "0001493152-26-006081", "price_sensitive": true}, {"form": "8-K", "date": "2026-01-05", "title": "Material event", "accession": "0001493152-26-000418", "price_sensitive": true}, {"form": "8-K", "date": "2025-12-15", "title": "Material event", "accession": "0001493152-25-027639", "price_sensitive": true}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000011", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000010", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000009", "price_sensitive": false}, {"form": "4", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000008", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000007", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001445815-25-000006", "price_sensitive": false}, {"form": "4/A", "date": "2025-11-18", "title": "PRIMARY DOCUMENT", "accession": "0001754429-25-000012", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-14", "title": "Quarterly report", "accession": "0001493152-25-023399", "price_sensitive": true}, {"form": "10-Q", "date": "2025-08-11", "title": "Quarterly report", "accession": "0001493152-25-011797", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-15", "title": "Quarterly report", "accession": "0001641172-25-010822", "price_sensitive": true}, {"form": "10-K", "date": "2025-04-03", "title": "Annual report", "accession": "0001641172-25-002614", "price_sensitive": true}, {"form": "8-K/A", "date": "2025-04-03", "title": "Form 8-K/A", "accession": "0001641172-25-002602", "price_sensitive": false}, {"form": "NT 10-K", "date": "2025-03-31", "title": "Form NT 10-K", "accession": "0001641172-25-001878", "price_sensitive": false}, {"form": "424B4", "date": "2025-02-18", "title": "Form 424B4", "accession": "0001493152-25-007059", "price_sensitive": false}, {"form": "EFFECT", "date": "2025-02-14", "title": "Form EFFECT", "accession": "9999999995-25-000468", "price_sensitive": false}], "performance": {"ticker": "BIXT", "has_prices": false, "summary": null, "buys": [{"who": "Hoberman Alan M", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 126000.0, "date": "2025-11-18", "score": 40.2, "ref_price": null, "return": null}, {"who": "PLATT DAVID", "person_type": "CEO", "person_label": "CEOs", "role": "CEO, Director, 10% Owner", "amount": 197522.204, "date": "2024-08-15", "score": 53.8, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}